Parathyroid imaging with (18)F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study

بواسطة Broos, Wouter A. M., Wondergem, Maurits, Knol, Remco J. J., van der Zant, Friso M.
الحاوية / القاعدة EJNMMI Res (2019)

Impact of fasting on (18)F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer

بواسطة Wondergem, Maurits, van der Zant, Friso M., Knol, Remco J. J., Pruim, Jan, de Jong, Igle J.
الحاوية / القاعدة EJNMMI Res (2016)

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy

بواسطة Borm, Frank J., Smit, Jasper, Oprea-Lager, Daniela E., Wondergem, Maurits, Haanen, John B. A. G., Smit, Egbert F., de Langen, Adrianus J.
الحاوية / القاعدة Cancers (Basel) (2021)

(99m)Tc-HDP bone scintigraphy and (18)F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer

بواسطة Wondergem, Maurits, van der Zant, Friso M., Knol, Remco J. J., Burgers, Anne Marij G., Bos, Siebe D., de Jong, Igle J., Pruim, Jan
الحاوية / القاعدة World J Urol (2017)

Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

بواسطة Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.
الحاوية / القاعدة PLoS One (2020)

Management impact of (18)F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study

بواسطة Meijer, Dennie, van Leeuwen, Pim J., Oosterholt, Pepijn M. J., Bodar, Yves J. L., van der Poel, Henk G., Hendrikse, N. Harry, Donswijk, Maarten L., Wondergem, Maurits, Vellekoop, Annelies E., van Moorselaar, R. Jeroen A., Nieuwenhuijzen, Jakko A., Oprea-Lager, Daniela E., Vis, André N.
الحاوية / القاعدة Eur J Nucl Med Mol Imaging (2021)